Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation

Molecular Microbiology

Volumn 82, Issue 6, 2011, Pages 1375-1391

  Wang, Xu De ^a   Gu, Jing ^a   Wang, Ting ^b,c   Bi, Li Jun ^c   Zhang, Zhi Ping ^a   Cui, Zong Qiang ^a   Wei, Hong Ping ^a   Deng, Jiao Yu ^a   Zhang, Xian En ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ETHIONAMIDE; INORGANIC PYROPHOSPHATASE; ISONIAZID; PROTEIN NUDC; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; COMPARATIVE STUDY; DIMERIZATION; DRUG DEGRADATION; DRUG INACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME POLYMORPHISM; GENE DELETION; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDC GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; ETHIONAMIDE; ISOENZYMES; ISONIAZID; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PYROPHOSPHATASES; SEQUENCE ALIGNMENT;

MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 83355173923     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2011.07892.x     Document Type: Article

References (47)

1. Ames, B.N., and Dubin, D.T. (1960) The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J Biol Chem 235: 769-775.
2. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K.S., Wilson, T., etal. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227-230.
3. Bardarov, S., Bardarov, S., Jr, Pavelka, M.S., Jr, Sambandamurthy, V., Larsen, M., Tufariello, J., etal. (2002) Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148: 3007-3017.
4. Baulard, A.R., Betts, J.C., Engohang-Ndong, J., Quan, S., McAdam, R.A., Brennan, P.J., etal. (2000) Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem 275: 28326-28331.
5. Bekierkunst, A. (1966) Nicotinamide-adenine dinucleotide in tubercle bacilli exposed to isoniazid. Science 152: 525-526.
6. Bernstein, J.W., Lott, A., Steinberg, B.A., and Yale, H.L. (1952) Chemotherapy of experimental tuberculosis. Am Rev Tuberc 65: 357-374.
7. Bessman, M.J., Frick, D.N., and O'Handley, S.F. (1996) The MutT proteins or 'nudix' hydrolases, a family of versatile, widely distributed, 'housecleaning' enzymes. J Biol Chem 271: 25059-25062.
8. Boshoff, H.I., Xu, X., Tahlan, K., Dowd, C.S., Pethe, K., Camacho, L.R., etal. (2008) Biosynthesis and recycling of nicotinamide cofactors in Mycobacterium tuberculosis. An essential role for NAD innonreplicating bacilli. J Biol Chem 283: 19329-19341.
9. Brossier, F., Veziris, N., Truffot-Pernot, C., Jarlier, V., and Sougakoff, W. (2011) Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 55: 355-360.
10. DeBarber, A.E., Mdluli, K., Bosman, M., Bekker, L.G., and Barry, C.E., 3rd (2000) Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proc Natl Acad Sci USA 97: 9677-9682.
11. Dunn, C.A., O'Handley, S.F., Frick, D.N., and Bessman, M.J. (1999) Studies on the ADP-ribose pyrophosphatase subfamily of the Nudix hydrolases and tentative identification of trgB, a gene associated with tellurite resistance. J Biol Chem 274: 32318-32324.
12. Fox, H.H. (1952) The chemical approach to the control of tuberculosis. Science 116: 129-134.
13. Frick, D.N., and Bessman, M.J. (1995) Cloning, purification, and properties of a novel NADH pyrophosphatase-evidence for a nucleotide pyrophosphatase catalytic domain in MutT-like enzymes. J Biol Chem 270: 1529-1534.
14. Gagneux, S., DeRiemer, K., Van, T., Kato-Maeda, M., de Jong, B.C., Narayanan, S., etal. (2006) Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 103: 2869-2873.
15. Hazbon, M.H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M.I., Varma-Basil, M., etal. (2006) Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 50: 2640-2649.
16. Heym, B., and Cole, S.T. (1992) Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum. Res Microbiol 143: 721-730.
17. Heym, B., Alzari, P.M., Honore, N., and Cole, S.T. (1995) Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 15: 235-245.
18. Hirsh, A.E., Tsolaki, A.G., DeRiemer, K., Feldman, M.W., and Small, P.M. (2004) Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci USA 101: 4871-4876.
19. Johnsson, K., and Schultz, P.G. (1994) Mechanistic studies of the oxidation of isoniazid by the catalase peroxidase from Mycobacterium tuberculosis. J Am Chem Soc 116: 7425-7426.
20. Kasǎrov, L.B., and Moat, A.G. (1972) Metabolism of nicotinamide adenine dinucleotide in human and bovine strains of Mycobacterium tuberculosis. J Bacteriol 110: 600-603.
21. Larsen, M.H., Vilchèze, C., Kremer, L., Besra, G.S., Parsons, L., Salfinger, M., etal. (2002) Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis. Mol Microbiol 46: 453-466.
22. LaVallie, E.R., DiBlasio, E.A., Kovacic, S., Grant, K.L., Schendel, P.F., and McCoy, J.M. (1993) A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Bio/Technology 11: 187-193.
23. Lee, A.S., Teo, A.S., and Wong, S.Y. (2001) Novel mutations in ndh inisoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 45: 2157-2159.
24. Lee, S., Kriakov, J., Vilcheze, C., Dai, Z., Hatfull, G.F., and Jacobs, W.R., Jr (2004) Bxz1, a new generalized transducing phage for mycobacteria. FEMS Microbiol Lett 241: 271-276.
25. Lei, B., Wei, C.J., and Tu, S.C. (2000) Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of InhA inhibitor. J Biol Chem 275: 2520-2526.
26. Middlebrook, G., and Cohn, M.L. (1953) Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 118: 297-299.
27. Miesel, L., Weisbrod, T.R., Marcinkeviciene, J.A., Bittman, R., and Jacobs, W.R., Jr (1998) NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J Bacteriol 180: 2459-2467.
28. Morlock, G.P., Metchock, B., Sikes, D., Crawford, J.T., and Cooksey, R.C. (2003) ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 47: 3799-3805.
29. Mostowy, S., Onipede, A., Gagneux, S., Niemann, S., Kremer, K., Desmond, E.P., etal. (2004) Genomic analysis distinguishes Mycobacterium africanum. J Clin Microbiol 42: 3594-3599.
30. Nguyen, M., Claparols, C., Bernadou, J., and Meunier, B. (2001) A fast and efficient metal-mediated oxidation of isoniazid and identification of isoniazid-NAD(H) adducts. Chembiochem 2: 877-883.
31. Nguyen, M., Quémard, A., Broussy, S., Bernadou, J., and Meunier, B. (2002) Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis. Antimicrob Agents Chemother 46: 2137-2144.
32. Rawat, R., Whitty, A., and Tonge, P.J. (2003) The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc Natl Acad Sci USA 100: 13881-13886.
33. Rozwarski, D.A., Grant, G.A., Barton, D.H., Jacobs, W.R., Jr, and Sacchettini, J.C. (1998) Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279: 98-102.
34. Schuck, P. (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J 78: 1606-1619.
35. Takayama, K., Wang, L., and David, H.L. (1972) Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2: 29-35.
36. Upton, A.M., Mushtaq, A., Victor, T.C., Sampson, S.L., Sandy, J., Smith, D.M., etal. (2001) Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism. Mol Microbiol 42: 309-317.
37. Vannelli, T.A., Dykman, A., and OrtizdeMontellano, P.R. (2002) The antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase. J Biol Chem 277: 12824-12829.
38. Vilchèze, C., Morbidoni, H.R., Weisbrod, T.R., Iwamoto, H., Kuo, M., Sacchettini, J.C., and Jacobs, W.R., Jr (2000) Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J Bacteriol 182: 4059-4067.
39. + ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob Agents Chemother 49: 708-720.
40. Vilchèze, C., Wang, F., Arai, M., Hazbon, M.H., Colangeli, R., Kremer, L., etal. (2006) Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 12: 1027-1029.
41. Vilchèze, C., Av-Gay, Y., Attarian, R., Liu, Z., Hazbón, M.H., Colangeli, R., etal. (2008) Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Mol Microbiol 69: 1316-1329.
42. + auxotrophy is bacteriocidal for the tubercle bacilli. Mol Microbiol 76: 365-377.
43. Wang, F., Langley, R., Gulten, G., Dover, L.G., Besra, G.S., Jacobs, W.R., Jr, and Sacchettini, J.C. (2007) Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med 204: 73-78.
44. Wilming, M., and Johnsson, K. (1999) Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid. Angew Chem Int Ed Engl 38: 2588-2590.
45. World Health Organization (2009) Global Tuberculosis Control. A short update to the 2009 report.
46. Xu, W., Dunn, C.A., and Bessman, M.J. (2000) Cloning and characterization of the NADH pyrophosphatases from Caenorhabditis elegans and Saccharomyces cerevisiae, members of a Nudix hydrolase subfamily. Biochem Biophys Res Commun 273: 753-758.
47. Zhang, Y., Heym, B., Allen, B., Young, D., and Cole, S. (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358: 591-593.